Lingjun Chuangtou

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
May 4, 2023	NeuExcell Therapeutics	$14.5M Pre-Series A	—	Jason Xinshan Kang, Huiju Xinxing, Huoshi Capital, Tao Shanshan, Suxin Yihe, Yijian Kexin, Xia Lei

Total Raised

N/A

Valuation

N/A

Key people at Lingjun Chuangtou.

Tao Shanshan

Key people at Lingjun Chuangtou.

Tao Shanshan